NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Epic Sciences

Epic Sciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://schillingbridgewinery.com/

Last Round

Series G

Apr 14, 2023

Total Funding Raised

$208.2M

Company Overview

Epic Sciences is a biotechnology company that develops diagnostic tests for the rapid and non-invasive detection of genetic and molecular changes in cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

liquid biopsycirculating tumor cellsCTCcancer diagnosticsprecision medicinecompanion diagnosticsblood testtumor heterogeneitytherapy selectionbiopharma solutionscancer screeningclinical trial supportcomputer visionmetastatic breast cancerdiagnostic services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epic Sciences Comps

Public and private peers based on sector, stage, and business model.

Epic Sciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Epic Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series GApr 14, 2023
Series FJun 1, 2022
Series ESep 12, 2018
Series DApr 28, 2017
Series CJul 30, 2014
Grant
Jan 25, 2013

Key People

Founding team and executive leadership

Jason Christiansen

Chief Technology Officer

Executive Team

Epic Sciences Investors

Notable investors and investment history

Epic Sciences investors
InvestorRounds
RusnanoMedInvestSeries C
Deerfield ManagementSeries E, Series F, Series G
National Cancer InstituteGrant
Roche Venture FundSeries B, Series C
Genomic HealthSeries E, Series D
Domain AssociatesSeries E, Series G, Series D, Series C, Series B
Altos Capital PartnersSeries E, Series D

Epic Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epic Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epic Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range37
Year Founded2008
Last FundingApr 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.